ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 217 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,211,000 | +78.7% | 54,879 | +0.2% | 0.07% | +54.3% |
| Q3 2020 | $2,357,000 | -2.2% | 54,748 | -1.8% | 0.05% | -6.1% |
| Q2 2020 | $2,409,000 | +57.2% | 55,771 | +4.7% | 0.05% | +36.1% |
| Q1 2020 | $1,532,000 | -54.6% | 53,245 | 0.0% | 0.04% | -45.5% |
| Q4 2019 | $3,377,000 | +270.3% | 53,245 | +64.5% | 0.07% | +247.4% |
| Q3 2019 | $912,000 | +8.7% | 32,360 | +2.2% | 0.02% | +5.6% |
| Q2 2019 | $839,000 | – | 31,649 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $20,836,128 | 14.83% |
| Aquilo Capital Management, LLC | 1,018,474 | $25,869,240 | 10.72% |
| Rokos Capital Management LLP | 1,675,921 | $41,537,702 | 3.07% |
| COMMODORE CAPITAL LP | 575,000 | $14,605,000 | 2.22% |
| Privium Fund Management B.V. | 259,036 | $6,579,514 | 2.21% |
| JOHNSON & JOHNSON | 247,598 | $6,288,989 | 2.05% |
| WEALTH EFFECTS LLC | 156,810 | $3,982,976 | 2.04% |
| M28 Capital Management LP | 67,400 | $1,711,960 | 1.94% |
| Evolutionary Tree Capital Management, LLC | 51,878 | $1,317,701 | 1.83% |
| Avidity Partners Management LP | 1,741,300 | $44,229,020 | 1.47% |